Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Klerfalk Pharma AB

Closing information (x1000 DKK)

Closing information 2024/12 2023/12 2022/12
Turnover 505 More Arrow 718 More Arrow 761
Financial expenses 170 More Arrow 1,994 Less Arrow 359
Earnings before taxes -136 More Arrow 115 Less Arrow -229
EBITDA -93 More Arrow 50 More Arrow 115
Total assets 7,370 More Arrow 7,863 Less Arrow 7,776
Current assets 261 More Arrow 446 More Arrow 812
Current liabilities 142 More Arrow 247 More Arrow 313
Equity capital 7,176 More Arrow 7,542 Less Arrow 7,380
- share capital 32 More Arrow 34 Less Arrow 33
Employees (average) 1 Equal arrow 1 Equal arrow 1

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 97.4% Less Arrow 95.9% Less Arrow 94.9%
Turnover per employee 505 More Arrow 718 More Arrow 761
Profit as a percentage of turnover -26.9% More Arrow 16.0% Less Arrow -30.1%
Return on assets (ROA) 0.5% More Arrow 26.8% Less Arrow 1.7%
Current ratio 183.8% Less Arrow 180.6% More Arrow 259.4%
Return on equity (ROE) -1.9% More Arrow 1.5% Less Arrow -3.1%
Change turnover -189 More Arrow -47 Less Arrow -334
Change turnover % -27% More Arrow -6% Less Arrow -31%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees % 0% Equal arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.